Research programme: microbiome related therapeutics - Enterome Bioscience

Drug Profile

Research programme: microbiome related therapeutics - Enterome Bioscience

Alternative Names: Cancer therapeutics - Enterome Bioscience; EO 2401; EO-2315; Metabolic disorders therapeutics - Enterome Bioscience

Latest Information Update: 19 Jan 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Enterome
  • Class Antineoplastics; Bacterial antigens; Cancer vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Glioblastoma
  • Research Cancer; Metabolic disorders

Most Recent Events

  • 12 Mar 2018 Enterome Biosciences plans a phase Ib trial for Cancer in 2018
  • 04 Jan 2018 Preclinical trials in Glioblastoma in France (unspecified route)
  • 18 Apr 2016 Early research in Cancer in France (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top